| | 基本信息 | | 收益评价 | | 基本信息 | | 收益评价 | | --- | --- | --- | --- | --- | --- | --- | --- | | 基金代码 | 基金简称 | 风险等级 | 最近一年 | 基金代码 | 基金简称 | 风险等级 | 最近一年 | | | | | 排名 | | | | 排名 | | 016810 | 信澳博见成长一年定开A | R3中国际 | 6/3751 | 019031 | 信澳医药健康A | R3中风险 | 338/3751 | | 011188 | 信澳星奕A | B3中国际 | 12/3751 | 011598 | 信溃量化多因子A(LOF) | R3中风险 | 518/3751 | | 012079 | 信澳新能源精选A | R4中高风险 | 38/3751 | 166107 | 信澳成长精选A | B3中国版 | 540/3751 | | 610001 | 信澳领先增长A | R3中风险 | 51/3751 | 166108 | 信澳转型创新A | R4中高风险 | 159/899 | | 020303 | 信澳星亮智选A | R3中国 ...

Core Viewpoint - The frequent turnover of senior management at Xinda Australia Fund reflects the intense competition and increasing performance pressure within the public fund industry, leading to potential personnel changes and reassignments [2][5][6]. Management Changes - On May 8, Xinda Australia Fund announced the resignation of Vice President Wei Qingkong, who will transition to the role of Chief Marketing Officer due to work arrangements [4][5]. - In the past six months, four vice presidents have left the company, including notable fund manager Feng Mingyuan, indicating a trend of high-level personnel changes [5][6]. - Wei Qingkong had been serving as Vice President since November 2021 and previously held the position of Chief Marketing Officer [5][6]. Fund Performance - Over 60% of Xinda Australia Fund's actively managed equity products have reported negative returns over the past three years, with 30 products showing losses, including 11 that fell over 30% [7]. - In contrast, some mixed bond funds have performed well, with four products achieving returns exceeding 10%, outperforming their peers by over 5 percentage points [7]. Financial Performance - In 2024, Xinda Australia Fund's operating income and net profit were reported at 644 million and 101 million respectively, representing year-on-year declines of 31.24% and 42.11% [8]. - The company attributes this decline to ongoing business structure optimization and a focus on reducing fund fees in response to regulatory requirements [8].